Resources from the same session
21O - Coformulated vibostolimab/pembrolizumab in advanced cervical cancer: KEYVIBE-005
Presenter: Alexandra Leary
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
22O - Association of biomarkers with response to coformulated vibostolimab/pembrolizumab (vibo/pembro) in metastatic cervical cancer (CC): Exploratory analysis from the phase II KEYVIBE-005 study
Presenter: Christophe Le Tourneau
Session: Proffered Paper session
Resources:
Abstract
23O - A randomized, phase III, double-blind study of chemoradiotherapy with or without pembrolizumab in patients with high-risk, locally advanced, cervical cancer (KEYNOTE-A18/ENGOT-cx11/GOG-3047): Results for patients enrolled in Asia
Presenter: Yang Xiang
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
Invited Discussant abstracts 21O+22O and 23O
Presenter: Ilaria Colombo
Session: Proffered Paper session
Resources:
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session
Resources:
Webcast
43O - Durvalumab (D) + carboplatin/paclitaxel (CP) + bevacizumab (B) followed by D, B + olaparib (O) maintenance (mtx) for newly diagnosed advanced ovarian cancer (AOC) without a tumour BRCA1/BRCA2 mutation (non-tBRCAm): Updated results from DUO-O
Presenter: Fabian Trillsch
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
44O - Safety and efficacy results in patients who received dose modifications in the phase III MIRASOL (GOG 3045/ENGOT-ov55) trial of mirvetuximab soravtansine vs investigator’s choice chemotherapy (ICC) in platinum-resistant ovarian cancer (PROC) with high folate receptor-alpha expression
Presenter: Susana Banerjee
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
34O - ROCSAN: A multicentric randomized phase II/III evaluating dostarlimab in combination with niraparib versus niraparib alone compared to chemotherapy in the treatment of endometrial/ovarian carcinosarcoma after at least one line of platinum-based chemotherapy – Preliminary results
Presenter: Isabelle Ray-Coquard
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
Invited Discussant abstracts 43O, 44O and 34O
Presenter: Bradley Monk
Session: Proffered Paper session
Resources:
Slides
Webcast